Sánchez-Fructuoso, A.I. (Ana I. )
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
Search Results
Now showing 1 - 1 of 1
- Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study(Wiley, 2021) Martín-Moreno, P.L. (Paloma L.); Sánchez-Fructuoso, A.I. (Ana I. ); Mazuecos, M.A. (María Auxiliadora); Mir, M. (Marisa); López-López, I. (Isabel); González-Rinne, A. (Ana); Coca, A. (Armando); Valero, R. (Rosalía); Ventura-Galiano, A. (Ana); Jimenez, C. (Carlos)BackgroundThe use of mycophenolic acid (MPA) in women during pregnancy causes an increase in miscarriages and birth defects with a typical embryopathy profile. Although epidemiological data does not suggest a greater risk among the offspring of male kidney transplant recipients, the European Medicines Agency and The Spanish Agency of Medicines and Medical Devices introduced the recommendation of using contraceptive methods.